Pharmaceutical News

RSS

Statins can help reduce lung damage in severe abdominal sepsis

Statins may be best known for their ability to reduce cholesterol, but a research report appearing in the May 2011 issue of the Journal of Leukocyte Biology shows that these same drugs could also play a crucial role in the reduction of lung damage resulting from severe abdominal sepsis and infection.

3 May 2011

FDA approves Perrigo's Minoxidil Foam, a generic version of Men's Rogaine Foam

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter Minoxidil Foam, a generic version of Men's Rogaine Foam.

3 May 2011

Oragenics announces availability of oral care probiotics for children and adults

Florida-based biopharmaceutical company Oragenics, Inc. has announced that its oral care probiotics for children and adults will be available in Australia and New Zealand through an exclusive agreement with Australian Pharmaceutical Industries, owner of the Priceline pharmacy retail chain, and one of the leading service providers to the pharmacy industry.

3 May 2011

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

AstraZeneca announced today that the U.S. Food and Drug Administration has approved the use of NEXIUM I.V. for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease with erosive esophagitis when oral therapy is not possible or appropriate.

3 May 2011

Sanofi Pasteur, EnGen Bio and Dyadic Nederland sign research deal for vaccine development

Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the biopharmaceutical, biofuels and industrial enzyme industries, announced today that its research and development subsidiary, Dyadic Nederland B.V., has entered into a research agreement with Sanofi Pasteur, the vaccines division of sanofi-aventis Group, and EnGen Bio, Inc.

3 May 2011

Hebei Aoxing Pharma receives Chinese patent for naloxone sublingual film

Aoxing Pharmaceutical, a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, announced that its operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company, has been granted a patent by the State Intellectual Property Office of The People's Republic of China for naloxone sublingual film.

3 May 2011

Boehringer Ingelheim, Eli Lilly receive FDA approval for Tradjenta to treat type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the U.S. Food and Drug Administration approved Tradjenta tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

3 May 2011

Watson introduces generic version of Concerta

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., has launched an authorized generic version of Concerta as part of an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc.

2 May 2011

Watson launches Generess Fe low-dose oral contraceptives in the U.S.

Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods.

2 May 2011

FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment

Seattle Genetics, Inc. announced today that the U.S. Food and Drug Administration has accepted for filing two Biologics License Applications for brentuximab vedotin, including one for the treatment of patients with relapsed or refractory Hodgkin lymphoma and one for the treatment of patients with relapsed or refractory systemic anaplastic large cell lymphoma.

2 May 2011

Assessment tool may help identify newborn exposure to methamphetamine

A scale used to assess the behavior of newborns exposed to methamphetamine before birth might be able to identify those children who will develop problems later on, according to a study that will be presented Sunday, May 1, at the Pediatric Academic Societies annual meeting in Denver.

2 May 2011

Talecris, Grifols enter 'Consent Agreement' with FTC Staff

Grifols, S.A. and Talecris Biotherapeutics Holdings Corporation, announced today that they have signed a "Consent Agreement" with the Staff of the Bureau of Competition of the US Federal Trade Commission by means of which the conditions for the merger transaction between both companies are agreed.

2 May 2011

Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma

A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.

2 May 2011

Many herbal medicines banned under EU directives

According to the new EU rules that came into force over the weekend, hundreds of herbal remedies are now banned. The laws are aimed at protecting consumers from potentially damaging “traditional” medicines.

1 May 2011

Extensive folic acid fortification of foods prevents neural tube defects in neonates

Neural tube defects in neonates are common in Germany compared with the rest of Europe. Extensive folic acid fortification of foods in Germany might prevent these in 85-100% of cases, Wolfgang Herrmann and Rima Obeid argue in this issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2011; 108[15]; 249-54).

30 Apr 2011

Bioniche Life Sciences opens new livestock vaccine manufacturing facility

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today officially opened its new Animal Health and Food Safety Vaccine Manufacturing Centre at its corporate headquarters in Belleville, Ontario, Canada.

30 Apr 2011

Prescriptions for narcotic-containing drugs often contain too much medication per dose

Parents who give young children prescription painkillers should take extra care to make sure they give just the right amount. What they may be surprised to learn, however, is that the dose given to them by the pharmacy could be too high, according to research to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.

30 Apr 2011

AHF advocates to attend drug giant Abbott Laboratories' Annual General Meeting

A group of advocates from AIDS Healthcare Foundation will attend drug giant Abbott Laboratories' Annual General Meeting Friday April 29 at 9:00am in Abbott Park, Illinois planning to speak at and question Abbott executives regarding Abbott's pricing and policies on its HIV/AIDS medications.

30 Apr 2011

Centocor Ortho Biotech Products withdraws NDA for trabectedin for treatment of women with ROC

Centocor Ortho Biotech Products, L.P., today announced that it has voluntarily withdrawn the New Drug Application for trabectedin for the treatment of women with recurrent ovarian cancer. The withdrawal is based on the U.S. Food and Drug Administration's recommendation that an additional Phase 3 study be conducted to obtain approval.

30 Apr 2011

Missouri American Water supports DEA's prescription drug collection program

Missouri American Water is providing information about the U.S. Drug Enforcement Administration's National Prescription Drug Take-Back Day to more than 150,000 households across Missouri through their water bills.

30 Apr 2011

Pharmaceutical News

Statins can help reduce lung damage in severe abdominal sepsis

FDA approves Perrigo's Minoxidil Foam, a generic version of Men's Rogaine Foam

Oragenics announces availability of oral care probiotics for children and adults

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

Sanofi Pasteur, EnGen Bio and Dyadic Nederland sign research deal for vaccine development

Hebei Aoxing Pharma receives Chinese patent for naloxone sublingual film

Boehringer Ingelheim, Eli Lilly receive FDA approval for Tradjenta to treat type 2 diabetes

Watson introduces generic version of Concerta

Watson launches Generess Fe low-dose oral contraceptives in the U.S.

FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment

Assessment tool may help identify newborn exposure to methamphetamine

Talecris, Grifols enter 'Consent Agreement' with FTC Staff

Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma

Many herbal medicines banned under EU directives

Extensive folic acid fortification of foods prevents neural tube defects in neonates

Bioniche Life Sciences opens new livestock vaccine manufacturing facility

Prescriptions for narcotic-containing drugs often contain too much medication per dose

AHF advocates to attend drug giant Abbott Laboratories' Annual General Meeting

Centocor Ortho Biotech Products withdraws NDA for trabectedin for treatment of women with ROC

Missouri American Water supports DEA's prescription drug collection program

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News